SE419647B - Sett att framstella tiazolisokinolinderivat - Google Patents

Sett att framstella tiazolisokinolinderivat

Info

Publication number
SE419647B
SE419647B SE7407049A SE7407049A SE419647B SE 419647 B SE419647 B SE 419647B SE 7407049 A SE7407049 A SE 7407049A SE 7407049 A SE7407049 A SE 7407049A SE 419647 B SE419647 B SE 419647B
Authority
SE
Sweden
Prior art keywords
tiazolisokinoline
derivatives
make
tiazolisokinoline derivatives
make tiazolisokinoline
Prior art date
Application number
SE7407049A
Other languages
English (en)
Swedish (sv)
Other versions
SE7407049L (ja
Inventor
K Harsanyi
K Takaes
P Kiss
L Szekeres
G Papp
E Benedek
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of SE7407049L publication Critical patent/SE7407049L/
Publication of SE419647B publication Critical patent/SE419647B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7407049A 1973-05-30 1974-05-28 Sett att framstella tiazolisokinolinderivat SE419647B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HUCI1381A HU170680B (ja) 1973-05-30 1973-05-30

Publications (2)

Publication Number Publication Date
SE7407049L SE7407049L (ja) 1974-12-02
SE419647B true SE419647B (sv) 1981-08-17

Family

ID=10994482

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7407049A SE419647B (sv) 1973-05-30 1974-05-28 Sett att framstella tiazolisokinolinderivat

Country Status (24)

Country Link
US (1) US3979397A (ja)
JP (3) JPS6014038B2 (ja)
AR (1) AR213611A1 (ja)
AT (1) AT349018B (ja)
BE (1) BE815679A (ja)
BG (1) BG22391A3 (ja)
CA (1) CA1037042A (ja)
CH (2) CH622807A5 (ja)
CS (2) CS227001B2 (ja)
DD (1) DD119595A5 (ja)
DE (1) DE2426267C2 (ja)
DK (1) DK151028C (ja)
EG (1) EG11439A (ja)
ES (1) ES426773A1 (ja)
FI (1) FI57262C (ja)
FR (1) FR2241309B1 (ja)
HU (1) HU170680B (ja)
IL (1) IL44895A (ja)
NL (1) NL176944C (ja)
NO (1) NO150281C (ja)
PL (1) PL101194B1 (ja)
SE (1) SE419647B (ja)
SU (1) SU569291A3 (ja)
YU (1) YU37172B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4062850A (en) * 1973-05-30 1977-12-13 Chinoin Pharmaceutical And Chemical Works Ltd. Thiazoloisoquinolines with coronary and respiratory effects
US4163786A (en) * 1973-05-30 1979-08-07 Chinoin Pharmaceutical And Chemical Works Ltd. Thiazoloisoquinolines with coronary and respiratory effects
NL169076C (nl) * 1975-08-06 1982-06-01 Rhone Poulenc Ind Werkwijze voor het bereiden of vervaardigen van farmacologische preparaten met een analgetische en antipyretische werking, alsmede werkwijze voor het bereiden van geneeskrachtige verbindingen, welke geschikt zijn voor gebruik in dergelijke preparaten.
US4108999A (en) * 1977-02-22 1978-08-22 Rhone-Poulenc Industries Thiazolo[3,4-b]isoquinoline derivatives, pharmaceutical compositions containing them and pharmaceutical methods using them
NL7908655A (nl) * 1978-12-07 1980-06-10 Rhone Poulenc Ind Nieuwe thienopyridine-derivaten, de bereiding ervan, alsmede farmaceutische preparaten, die de nieuwe derivaten bevatten.
HU178454B (en) * 1979-07-02 1982-05-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing new isoquinoline derivatives containing sulphur
JPH0332569Y2 (ja) * 1986-05-27 1991-07-10

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3042671A (en) * 1959-10-07 1962-07-03 Pfizer & Co C Benzopyridocolines
US3455933A (en) * 1966-11-15 1969-07-15 American Home Prod Thiazolo and thiazino isoquinoline derivatives
US3665007A (en) * 1970-05-04 1972-05-23 Squibb & Sons Inc Thiazolo (3,4-a) benzimidazoles and derivatives thereof

Also Published As

Publication number Publication date
US3979397A (en) 1976-09-07
JPS57145884A (en) 1982-09-09
DE2426267C2 (de) 1984-02-09
CH622807A5 (ja) 1981-04-30
DK289774A (ja) 1975-01-20
JPS57145885A (en) 1982-09-09
HU170680B (ja) 1977-08-28
JPS591714B2 (ja) 1984-01-13
PL101194B1 (pl) 1978-12-30
NL176944B (nl) 1985-02-01
CA1037042A (en) 1978-08-22
YU37172B (en) 1984-08-31
JPS5047999A (ja) 1975-04-28
FI164474A (ja) 1974-12-01
FR2241309B1 (ja) 1977-11-04
BE815679A (fr) 1974-09-16
FI57262B (fi) 1980-03-31
DK151028C (da) 1988-03-14
NO150281B (no) 1984-06-12
DK151028B (da) 1987-10-12
JPS6014038B2 (ja) 1985-04-11
ES426773A1 (es) 1976-07-16
NL176944C (nl) 1985-07-01
FI57262C (fi) 1980-07-10
DD119595A5 (ja) 1976-05-05
CS226901B1 (en) 1984-04-16
FR2241309A1 (ja) 1975-03-21
AT349018B (de) 1979-03-12
NO741939A (no) 1974-12-03
EG11439A (en) 1978-12-31
SU569291A3 (ru) 1977-08-15
BG22391A3 (bg) 1977-02-20
IL44895A (en) 1979-07-25
IL44895A0 (en) 1974-07-31
YU148074A (en) 1982-06-18
AR213611A1 (es) 1979-02-28
JPS5842195B2 (ja) 1983-09-17
NL7407280A (ja) 1974-12-03
CS227001B2 (en) 1984-04-16
NO150281C (no) 1984-09-19
DE2426267A1 (de) 1975-01-09
SE7407049L (ja) 1974-12-02
ATA433674A (de) 1978-08-15
CH620220A5 (ja) 1980-11-14

Similar Documents

Publication Publication Date Title
SE411545B (sv) Sett att framstella chalkonetrar.
SE408426B (sv) Sett att framstella d-homo-20-ketopregnaner
SE7711848L (sv) Sett att framstella nya 5-metyl-7-hydroxi-isoflavonderivat
SE417316B (sv) Sett att framstella piperazinyl-kinoxalin-foreningar
SE410600B (sv) Sett att framstella nya arylaminopyrimidinderivat
SE417507B (sv) Sett att framstella 2-arylamino-2-imidazolinderivat
SE413598B (sv) Sett att framstella 7-amino-delta?723-cefem-derivat
SE382215B (sv) Sett att framstella kromanderivat
SE420602B (sv) Sett att framstella pyrazin-3-metoxi-2-karboxamidderivat
SE418205B (sv) Sett att framstella flerskiktskartong
SE399255B (sv) Sett att framstella kinazolinonderivat
SE399270B (sv) Sett att framstella spirolaktonsteroider
SE425850B (sv) Sett att framstella abietamidderivat.
SE417981B (sv) Sett att framstella cefalosporinforeningar
SE417211B (sv) Sett att framstella indenyl-3-acetoglucuronider
SE419647B (sv) Sett att framstella tiazolisokinolinderivat
SE427655B (sv) Sett att framstella abietamidderivat
SE415653B (sv) Sett att framstella cykloalkylfenoxikarboxylsyraderivat
SE417427B (sv) Sett att framstella 5,6-benso-gamma-pyronderivat
SE400078B (sv) Sett att framstella kinazolinonderivat
SE397679B (sv) Sett att framstella kinazolinonderivat
SE401184B (sv) Sett att framstella morfolinderivat
SE428471B (sv) Sett att framstella imidazolderivat
SE417830B (sv) Sett att framstella vissa sulfonylmetylsubstituerade bicykloalkanoner
SE400281B (sv) Sett att framstella kinazolinonderivat

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7407049-1

Effective date: 19921204

Format of ref document f/p: F